✦ LIBER ✦

Topical treatment with BV-araU of immunosuppressed and immunocompetent shaved mice cutaneously infected with herpes simplex virus type 1

✍ Scribed by Katsushi Ijichi; Noriyuki Ashida; Sailesh Varia; Haruhiko Machida

Book ID: 118393039
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 618 KB
Volume: 21
Category: Article
ISSN: 0166-3542
DOI: 10.1016/0166-3542(93)90066-r

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of oral treatment with BV-araU

Efficacy of oral treatment with BV-araU against cutaneous infection with herpes simplex type 1 in shaved mice

✍ H. Machida; J. Takezawa; K. Ijishi 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Efficacy of oral treatment with BV-araU

Efficacy of oral treatment with BV-araU against cutaneous infection with herpes simplex type 1 in shaved mice

✍ Haruhiko Machida; Katsushi Ijichi; Junichi Takezawa 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 548 KB

Topical treatment of cutaneous herpes si

Topical treatment of cutaneous herpes simplex virus-1 infection in mice with a specially formulated caffeine gel (Cafon)

✍ Yamamura, Jun-ichi; Koyasu, Makiko; Sato, Hitoshi; Kurokawa, Masahiko; Yoshida, 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 473 KB

Efficacy of topical treatment with BV-ar

Efficacy of topical treatment with BV-araU cream against cutaneous infection with herpes simplex type 1 in shaved mice : H. Machida, K. Ijichi, N. Ashida, and S. Varia∗ Biology Laboratory, Yamasa Shoyu Co., Ltd., Choshi, Japan and ∗Bristol-Myers Squibb Pharmaceutical Institute, New Bruswick, NJ

📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Acyclovir treatment of experimental geni

Acyclovir treatment of experimental genital herpes simplex virus infections. I. Topical therapy of type 2 and type 1 infections of mice

✍ Earl R. Kern; James T. Richards; James C. Overall Jr.; Lowell A. Glasgow 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 762 KB

Successful treatment of aciclovir and fo

Successful treatment of aciclovir and foscarnet resistant Herpes simplex virus lesions with topical imiquimod in patients infected with human immunodeficiency virus type 1

✍ Anne-Sophie Lascaux; Eric Caumes; Claire Deback; Giovanna Melica; Dominique Chal 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

## Abstract Aciclovir (ACV)‐resistant __Herpes simplex virus__ type‐2 (HSV‐2) infections are observed commonly in patients also infected with HIV‐1. The use of foscarnet (FOS) in these patients may also lead to resistance. This situation can become a difficult therapeutic challenge. Four cases of p